A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants

Clinical trial NCT03182504 · COMPLETED

Trial details

NCT number: NCT03182504
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gram-negative Bacterial Infections

Start date: 2017-06-15
Primary completion: 2017-08-10
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.